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ABSTRACT
Streptococcus pneumoniae is the main etiological agent of community-acquired pneumonia and a major cause of mortality and
morbidity among children and the elderly. Genome sequencing of several pneumococcal strains revealed valuable information
about the potential proteins and genetic diversity of this prevalent human pathogen. However, little is known about its
transcriptional regulation and its small regulatory noncoding RNAs. In this study, we performed deep sequencing of the
S. pneumoniae TIGR4 strain RNome to identify small regulatory RNA candidates expressed in this pathogen. We discovered
1047 potential small RNAs including intragenic, 59- and/or 39-overlapping RNAs and 88 small RNAs encoded in intergenic
regions. With this approach, we recovered many of the previously identified intergenic small RNAs and identified 68 novel
candidates, most of which are conserved in both sequence and genomic context in other S. pneumoniae strains. We confirmed
the independent expression of 17 intergenic small RNAs and predicted putative mRNA targets for six of them using bio-
informatics tools. Preliminary results suggest that one of these six is a key player in the regulation of competence development.
This study is the biggest catalog of small noncoding RNAs reported to date in S. pneumoniae and provides a highly complete
view of the small RNA network in this pathogen.
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INTRODUCTION
Streptococcus pneumoniae, or pneumococcus, is a Gram-
positive bacterium able to cause a diverse number of diseases
(pneumonia, sinusitis, peritonitis, otitis media) and invasive
processes (meningitis, septicemia), mainly in children, the
elderly, and the immuno-compromised population. Accord-
ing to a recent report of the World Health Organization,
pneumonia is the leading cause of death in children younger
than 5 yr and is responsible for 1.6 million casualties each
year, and S. pneumoniae and Haemophilus influenzae are
the predominant causal agents (Howie and Adegbola 2006;
Wardlaw et al. 2006; Scott 2008) (http://www.who.int).
Moreover, pneumococci are responsible for 40% of the
cases of chronic otitis media that, although less serious, affect
approximately a third of all children during their first 3 yr of
life. However, despite its importance as a pathogen, some
relevant aspects concerning the pathophysiology of pneu-
mococcal diseases remain unresolved.
S. pneumoniae often colonizes the nasopharynx of healthy
individuals, behaving as harmless commensal bacteria
(Margolis et al. 2010). The transition from commensal to
opportunistic pathogen often occurs after a respiratory tract
infection and is triggered by host and bacterial factors that
are still unknown. Progression into the lungs or middle ear
and the infection process exposes S. pneumoniae to numer-
ous environmental changes and stress conditions, and the
response to these different environments plays an important
role in pneumococcal virulence.
In the last decade, small noncoding RNAs have emerged
as crucial bacterial regulators that enable the cell to adjust
its physiology to environmental changes (Wassarman et al.
1999; Waters and Storz 2009). These RNA regulators make
up a very heterogeneous group of molecules that can be
generated either via processing or as primary transcripts,
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with the latter being the most abundant class of known
noncoding RNAs. They can be encoded as part of the mRNA
that they regulate (cis-acting RNAs), such as riboswitches
or 59 untranslated regions (UTRs), or as independent tran-
scripts (trans-acting RNAs). Additionally, trans-acting RNAs
may be encoded in cis or in trans relative to their target
transcript. Trans-acting small RNAs encoded in intergenic
regions (sRNAs) have been the focus of most previous
studies on small noncoding RNAs in bacteria and are
considered the paradigm of these regulators. Most sRNAs
exert their action by one of two mechanisms: (1) base-
pairing with their mRNA target, modulating its translation
and/or stability; or (2) binding to proteins, normally tran-
scriptional regulators, antagonizing their function. In addi-
tion, there are sRNAs with other specific functions, such as
tmRNA, 6S RNA, 4.5S RNA, or RNase P, which perform
important housekeeping functions and are consequently
highly conserved in bacteria (Gottesman 2002; Brantl 2009;
Repoila and Darfeuille 2009; Waters and Storz 2009).
In recent years, many sRNAs have been discovered in
various bacterial species using different approaches (Altuvia
2007; Livny and Waldor 2007; Landt et al. 2008; Livny
et al. 2008; Sittka et al. 2008; Sharma and Vogel 2009;
Sharma et al. 2010). Although most of these studies have
been made in Escherichia coli and other Gram-negative
bacteria, sRNAs have also recently been identified in some
Gram-positive bacteria, including pathogens such as Bacil-
lus anthracis (Passalacqua et al. 2009), Lysteria monocyto-
genes (Christiansen et al. 2006; Mandin et al. 2007), and
Staphylococcus aureus (Boisset et al. 2007; Geissmann et al.
2009); and model systems such as Streptomyces coelicolor
(Swiercz et al. 2008) and Bacillus subtilis (Rasmussen et al.
2009; Irnov et al. 2010). However, despite all of the available
data and the dedicated efforts of researchers, the function of
the majority of these sRNAs is still unknown. Nevertheless, it
is clear that sRNAs coordinate complex networks of stress
adaptation and play key roles in pathogenesis, colonization,
and persistence, allowing the pathogen to adapt its metabolic
needs during infection and to express its virulence genes
when required. A variety of sRNAs have been identified in
pathogenic bacteria, and some of them have been proven
to directly modulate virulence (Pichon and Felden 2005;
Chaturongakul et al. 2008; and reviews Romby et al. 2006;
Toledo-Arana et al. 2007).
In S. pneumoniae, however, the study of small regulatory
RNAs is still in its early stages. The first sRNAs to be
described were found by serendipity in a search for genes
directly regulated by the CiaRH two-component system in
the R6 strain (Halfmann et al. 2007). CiaRH is involved in
b-lactam resistance, autolysis, virulence, and competence
development and is thought to regulate the expression of
15 genes, five of which encode intergenic sRNAs (named
csRNAs1 to 5). CiaRH positively regulates the expression of
these sRNAs, but their function, other than csRNA4 and 5,
which affect stationary-phase autolysis (Halfmann et al.
2007), is still unknown. Additionally, a computational pre-
diction of sRNAs in the TIGR4 strain (serotype 4) identified
63 putative sRNAs encoded in intergenic regions (IGRs)
(Livny et al. 2006), nine of which were further confirmed by
Northern blotting in the D39 strain (serotype 2) (Tsui et al.
2010). In the course of this study, 50 sRNAs were identified
in S. pneumoniae TIGR4 using genome-tilling arrays, 13
of which were validated by RT-PCR (Kumar et al. 2010).
However, only eight out of the 50 overlapped with the 63
computationally predicted sRNAs (Livny et al. 2006), in-
dicating important discrepancies between the different sRNA
data sets.
In this study, we describe the identification of small
noncoding RNAs in S. pneumoniae serotype 4 clinical isolate
TIGR4 using a deep-sequencing approach. We recovered
many of the sRNAs previously detected in the S. pneumoniae
TIGR4 strain and identified 68 novel candidates. This work
significantly increases the number of small RNA regulators
identified in S. pneumoniae. In addition, we provide evidence
suggesting a role of one intergenic sRNA in modulating
competence.
RESULTS AND DISCUSSION
S. pneumoniae small noncoding RNA sequencing
It was previously demonstrated that the gene expression
pattern in S. pneumoniae cells grown in vitro in a liquid
culture (planktonic cells) is similar to that found in pneu-
mococci isolated from the blood (Oggioni et al. 2006).
Therefore, to mimic the in vivo conditions as much as pos-
sible, we used in vitro planktonic growing cells to investigate
the expression of small noncoding RNAs. For this purpose,
capsulated S. pneumoniae TIGR4 cells were grown to mid-
logarithmic phase, and total RNA was extracted. To enrich
our sample for small-sized RNAs, the extract was size-
fractionated, and the RNA fraction between 100 and 400
nt in length was selected (see workflow in Fig. 1). This size
fractionation excluded most of the mature tRNA species,
which are z75 nt in length (and are always <90 nt), but not
the 5S rRNA (z130 nt), which is the other highly abundant
transcript in the size-selected fraction. To address this
problem, we developed a 5S rRNA depletion step using
hybridization with a complementary biotinylated oligonucle-
otide (see Materials and Methods). Such treatment effec-
tively removed 87% of the 5S rRNA, as measured by
quantitative RT-PCR (RT-qPCR) (data not shown) from
downstream analysis. Further addition of a poly(C) tail,
followed by ligation of specialized adapter molecules to
the 59 and 39 ends, was used to synthesize a cDNA library
by reverse transcription that was then analyzed by 454
pyrosequencing.
A total of 157,592 cDNA reads ($30 nt) were obtained,
of which 40,224 were shorter than 50 nt or did not meet the
minimum quality criteria. The remaining 117,368 cDNA
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reads were filtered to eliminate those sequences derived
from 16S and 23S rRNAs, as well as the 5S rRNA and tRNA
that escaped the depletion steps. In the end, 27,978 cDNA
sequences were obtained, of which 15,567 were successfully
mapped to the S. pneumoniae TIGR4 genome (Tettelin et al.
2001) (z90% of the total cDNA reads analyzed matched the
S. pneumoniae genome). A second filtering step to remove
highly repetitive or chimeric sequences, as well as RNAs that
partially overlapped with one or more rRNAs or tRNAs,
resulted in 2308 cDNA reads that were finally assembled into
1047 different contig sequences for po-
tential RNAs (Supplemental Tables S1
and S2). Despite the RNA size selection
performed to enrich our sample in RNAs
from 100 to 400 nt in length, 840 reads
corresponded to 539 contig sequences
between 50 and 99 nt (Supplemental
Table S2), while the remaining 1468
reads corresponded to 508 contig se-
quences ranging between 100 and 440 nt
in length (Supplemental Table S1). The
coding strand was determined for many,
but not all, of the cDNA contig se-
quences by poly(C)-tail sequence de-
tection. The 1047 cDNA contigs were
classified into five types depending on
their genomic location (Fig. 2; Supple-
mental Tables S1, S2). The most abun-
dant class (781 contigs) corresponded
to intragenic RNAs that mapped en-
tirely (or with IGRs < 10 nt) within re-
gions annotated as open reading frames
(ORFs) in the TIGR4 genome. Many of
the contig sequences encompassed both
intergenic ($10 nt) and intragenic (>10
nt) regions, partially overlapping the
59 or 39 ends of an ORF. Because the
coding strand could not be determined
for all of them, they were generally clas-
sified as overlapping RNAs—57 contigs
corresponded to 59-overlapping RNAs
and 78 contigs corresponded to 39-over-
lapping RNAs. Additionally, 45 cDNA
contig sequences simultaneously over-
lapped with two contiguous genes, span-
ning the 39 and the 59 ends of the genes
and the IGR between them. These con-
tigs were classified as 59/39-overlapping
RNAs, in which both overlapping regions
are >10 nt. Finally, there was another
class of cDNAs (86 contigs) that corre-
sponded to RNAs that entirely mapped
within IGRs (or with intragenic regions
#10 nt). These are candidates for the so-
called intergenic sRNAs, 44 of which
were shorter than 100 nt (Tables 1, 2).
In total, 13% of the cDNA sequences obtained (135
contigs) corresponded to RNAs that partially overlap with
one ORF. Transcript leaders, or UTRs, may have special-
ized functions that affect the stability, the fate or, more
often, the transcription/translation of cis-encoded genes
(Irnov et al. 2006). In these cases, the formation of a sec-
ondary structure is normally required within the UTR.
Sixteen out of the 135 overlapping RNAs harbored inter-
genic regions longer than 100 nt (seven were 59 overlapping
FIGURE 1. Small RNA library generation and data analysis pipeline. Total RNA was
processed to enrich the sample for small-sized RNAs by two consecutive PAA gel fractionation
and elution steps. The 5S rRNA was depleted by hybridization with a complementary
biotinylated oligonucleotide. The small RNA fraction was C-tailed with E. coli poly(A)
polymerase and reverse-transcribed using a poly(G) oligonucleotide; the cDNA obtained was
subjected to 454 sequencing on the Genome Sequencer FLX System from the Lifesequencing
S.L. company. The total number of reads obtained, the reads that successfully mapped to the
S. pneumoniae TIGR4 genome, and the total number of cDNA contigs finally obtained ($50 nt)
are indicated. Six percent PAA gels stained with ethidium bromide show RNA from the
fractionation procedure. (St) The RNA marker used.
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and nine were 39 overlapping), which might support sta-
ble secondary structure elements (Supplemental Fig. S1).
Whether any of these overlapping RNAs may act as a cis-
regulator is a very interesting question that remains to be
answered.
Small RNAs encoded in intergenic regions
Small RNAs encoded in the intergenic regions are the
paradigm of regulatory RNAs in bacteria. In this study, we
identified a total of 86 candidates for small regulatory
RNAs encoded in IGRs (sRNAs). Of those, 18 had been
previously identified by genome tilling arrays (Kumar et al.
2010), and 68 are novel candidates (Tables 1, 2). Only six of
the 18 sRNAs previously identified were detected by RT-
PCR, and none of them was studied further. In addition,
we recovered eight of the 63 sRNAs predicted by compu-
tational analysis (srn029, srn068, srn239, srn254, srn270,
srn308, trn0696, and trn0761) (Livny et al. 2006), of which
three (srn029, srn239, and srn308) overlapped with the 18
candidates detected by tilling arrays. We also identified
the previously known csRNA3 (trn0012) and csRNA5
(srn061), which are two of the five most studied sRNAs in
S. pneumoniae (Halfmann et al. 2007). However, csRNA1, 2,
and 4 were not detected. The expression of these five sRNAs
is controlled by the CiaRH two-component system, and they
are likely to be expressed in similar conditions. The five
csRNAs are highly similar in sequence, mainly the csRNAs1
to 4, which differ only at a few bases (Halfmann et al. 2007),
and it is likely that the Reference Mapper software used
for the analysis was not able to discriminate between them,
thereby assigning all reads to the same csRNA3 contig.
srn142 and srn368 were previously identified as intergenic
sRNAs (SN10 and SN24) (Kumar et al. 2010). These RNAs
appeared to be 39 overlapping in our analysis (the former is
an antisense RNA, and the latter is a 39-UTR RNA) because
they are longer than the previous study reported and overlap
with the downstream gene. However, because the sequencing
procedure we used does not allow us to determine the exact
transcription initiation and termination sites, these RNAs
were studied as sRNAs (Table 1). Therefore, in this study, we
analyzed a total of 88 small RNAs.
To gain some clues about the possible function of these
sRNAs, we performed a search with all RNA sequences
against the Rfam database (http://rfam.sanger.ac.uk/), a col-
lection of sequence alignments and profiles of noncoding
RNA families (Gardner et al. 2009). We found 11 sRNAs
with homology with well-characterized RNA families (see
Tables 1, 2). Three of them—srn098, srn226, and srn395—
were identified as the housekeeping sRNAs RNase P,
tmRNA, and 6S RNA, respectively. These RNAs are known
to be widespread in bacteria and play essential, specific
roles related to stress and stationary-phase adaptation
and tRNA maturation. Four other sRNAs (srn029, srn142,
srn176, and trn0358) were predicted to be FMN or TPP
riboswitches, common 59 UTRs that are able to bind a
target molecule (e.g., a metabolite), change its secondary
structure, and affect the transcription or translation of
downstream genes (Nudler and Mironov 2004). The
srn239, srn267, and srn308 appeared to be ribosomal pro-
tein leader autoregulatory structures (L20, L21, and L10
leader regions), commonly found in the 59 UTRs of
ribosomal protein genes, and trn0273 was shown to be a
conserved RNA motif located upstream of rRNA methyl-
transferase-encoding genes (Weinberg et al. 2007). With
this analysis, we could assign putative functions to 11 of the
pneumococcal sRNAs identified, eight of which were pre-
dicted to be cis-regulators. The remaining 77 sRNAs, how-
ever, corresponded to unknown RNAs with no homology
with any family in the Rfam database and appear to rep-
resent a novel set of sRNAs in pneumococci.
Comparative genomics and computational
analysis of sRNAs
sRNAs appear to be quite conserved among Gram-negative
bacteria, especially in the g-proteobacterial class, probably
because they have common mRNA targets or specially
optimized secondary structures (Irnov et al. 2010). In stark
contrast, such conservation is much more vague in Gram-
positive bacteria, where it is mostly confined to the genus or
even to the species level (Geissmann et al. 2009; Rasmussen
et al. 2009; Marx et al. 2010). To explore the conservation of
the sRNA candidates identified in this study, we used BLAST
to analyze their taxonomical distribution in various pneu-
mococcal strains and other related and unrelated bacterial
species (Supplemental Table S3). To ensure confidence in
the analysis, we selected only those candidates $100 nt
in length. The results obtained revealed that seven sRNAs
were unique to S. pneumoniae, because they could not be
FIGURE 2. Distribution of the small RNAs isolated from the S.
pneumoniae TIGR4 strain. The sector diagram shows the distribution
of the 1047 cDNA contigs obtained (after the removal of rRNAs and
tRNAs) with regard to their origin and genetic context. The chart
shows the number of RNAs assigned to each of the following
categories: intragenic RNAs that overlap entirely with an ORF; 59-
or 39-overlapping RNAs that overlap with the 59 or 39 end of an ORF;
59/39-overlapping RNAs that overlap with two adjacent genes simul-
taneously; and intergenic sRNAs, RNAs entirely encoded in intergenic
regions.
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TABLE 1. Predicted sRNAs $100 nt in length in S. pneumoniae TIGR4
ID
Genome









srn026 144,217 .. 144,338 117 1 SP_0145(+) SP_0146(+) 10/1
srn029 171,513 .. 171,666 155 5 SP_0178() ruvA(+) () FMN riboswitch
(6.60E-19)
Yes/yes SN4 10/2
srn049 202,519 .. 202,622 104 4 rpmD(+) rplO(+) (+) 10/1
srn061 209,805 .. 209,915 110 10 SP_0239(+) SP_0240(+) (+) Yes/no SN35/
csRNA5
10/1
srn068 248,144 .. 248,290 147 1 SP_0272(+) SP_0273(+) 10/2
srn081 273,681 .. 273,799 117 3 SP_0297(-) SP_0298(-) 2/0
srn098 350,624 .. 351,014 391 14 SP_0372(+) SP_0373(+) (+) RNase P
(8.69E-110)
Yes/yes SN8 10/11
srn135 438,151 .. 438,276 126 3 SP_0461() SP_0462(+) (+) Yes/yes 2/0
srn141 463,613 .. 463,725 113 1 SP_0482(+) SP_0483(+) (+) 10/1
srn145 470,561 .. 470,657 104 1 SP_0493(+) pyrG(+) (+) 10/2
srn151 501,260 .. 501,364 101 1 SP_0519(+) SP_0520() 10/1
srn157 547,597 .. 547,699 103 1 SP_578(+) pheS(+) (+) 10/5
srn164 596,533 .. 596,633 100 1 SP_0629(+) rplK(+) (+) 10/1
srn176 681,822 .. 681,975 153 7 SP_0715(+) SP_0716(+) (+) TPP riboswitch
(2.4E-18)
Yes/yes SN13 10/3
srn206 781,187 .. 781,305 120 10 SP_0831(+) SP_0832(+) () Yes/yes 10/0
srn218 808,047 .. 808,148 101 1 tRNAGln(+) rpsA(+) 10/1
srn226 821,938 .. 822,273 337 67 SP_0873(+) SP_0874() (+) tmRNA
(5.17E-28)
Yes/yes SN16 10/5
srn231 853,483 .. 853,606 118 2 SP_0897(+) SP_0899(+) SN17 10/0
srn235 869,494 .. 869,745 251 7 SP_0915() SP_0916(+) (+) Yes/no SN20 10/0
srn239 907,201 .. 907,325 124 66 SP_0958(+) infC(+) (+) L20 leader
(4.039E-16)
SN40 10/8
srn241 909,055 .. 909,180 122 2 SP_0962(+) SP_0963(+) (+) 10/1
srn249 928,077 .. 928,215 135 2 prsA(+) SP_0984() 10/5
srn254 956,788 .. 956,896 110 2 tRNAThr(+) SP_1013(+) Yes/no 10/9
srn266 1,035,461 .. 1,035,582 120 1 eutD(+) SP_1102() (+) Yes/yes 10/7
srn267 1,037,099 .. 1,037,218 121 2 SP_1104(+) rplU(+) (+) L21 leader
(7.00E-10)
SN41 10/4
srn270 1,038,198 .. 1,038,302 104 1 rpmA(+) SP_1108() 10/1
srn277 1,071,102 .. 1,071,212 112 2 SP_1142(+) SP_1143(+) 0/0
srn279 1,102,805 .. 1,102,928 124 1 SP_1166() PyrC() 10/0
srn299 1,214,235 .. 1,214,353 119 5 SP_1278() SP_1279() () Yes/yes SN42 10/1
srn308 1,275,575 .. 1,275,711 137 29 rplJ() SP_1356() () L10 leader
(6.813E-12)
Yes/yes SN43 10/4
srn317 1,334,472 .. 1,334,582 108 1 SP1415() queA(+) () 10/2
srn319 1,360,540 .. 1,360,646 104 1 SP_1440(+) SP1441(-) 10/1
srn351 1,461,067 .. 1,461,175 109 3 SP_1551() SP_1552(+) () SN44 10/2
srn395 1,706,693 .. 1,706,886 188 79 SP_1790(+) SP_1791() (+) 6S
(9.59E-16)
Yes/yes SN34 10/5
srn400 1,731,603 .. 1,731,720 117 3 SP_1820() SP_1821() () Yes/yes 10/4
srn435 1,872,034 .. 1,872,146 111 1 SP_1963() SP_1964() 10/2
srn448 1,901,982 .. 1,902,084 101 1 SP_1998(+) SP_1999() (+) 10/2
srn477 1,984,831 .. 1,984,969 136 1 SP_2075() SP_2076() 10/1
srn478 1,986,359 .. 1,986,458 100 1 SP_2075() SP_2077() 10/1
srn491 2,005,533 .. 2,005,674 139 6 Sp_2097() SP_2098() () Yes/yes SN45 10/1
srn502 2,086,090 .. 2,086,326 238 16 SP_2168(+) SP_2169() (+) Yes/yes SN27 10/1
srn503 2,086,474 .. 2,086,599 125 1 SP_2168(+) SP_2169() 10/1
srn142* 467,168 .. 467,450 282 57 SP_0486(+) SP_0487() (+) FMN riboswitch
(2.28E-15)
Yes/yes SN10 10/1
srn368* 1,529,977 .. 1,530,163 185 2 SP_1629(+) SP_1630(+) (+) SN24 10/4
*59-overlapping RNAs that were analyzed as sRNAs.
aSequence conservation and taxonomical dispersion were analyzed in 10 additional pneumococcal strains and another 11 Streptococcus
species that have completely sequenced genomes (Supplemental Table S3). Numbers denote the number of bacterial pneumococcal strains/
streptococcal species in which srn homologs have been found. Homologs were detected by BLASTusing a 40% identity and an E-value of 0.001
as the thresholds.
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identified in other streptococcal species (Table 1). The re-
maining 37 appeared to also be present in other streptococci,
although most of them (17 sRNAs) were only found in
Streptococcus mitis, the closest species to pneumococcus.
Interestingly, only srn029 was identified in a nonstrepto-
coccal bacterium, the Gram-positive B. subtilis, but not in
any Gram-negative species. Therefore, it appears that most
of the sRNAs identified are widespread in pneumococcal
strains but that they are quite species- and genus-specific.
In total, 41 sRNAs showed 90%–100% sequence identity
in all S. pneumoniae strains and could be considered
universal pneumococcal sRNAs (Supplemental Fig. S2).
However, srn081 and srn135 were present only in two
strains, and srn277 appeared to be exclusive to TIGR4.
Additionally, 34 out of the 41 pneumococcal sRNAs shared
one or, in most cases, both flanking genes in all strains
(Supplemental Table S4). The high degree of sequence and
genomic context conservation observed is suggestive of
TABLE 2. Predicted tiny sRNAs (50–99 nt in length) in S. pneumoniae TIGR4
ID
Genome
position Length Reads Left gene Right gene Strand
Rfam
(E-value) Names
trn0012 24,175 .. 24,264 90 18 SP_0019(+) SP_0020(+) (+) SN1/csRNA3
trn0027 79,336 .. 79,386 51 1 SP_0071(+) SP_0072(+)
trn0036 91,593 .. 91,651 59 1 rpsD(+) SP_0087()
trn0052 120,766 .. 120,838 73 1 SP_0117(+) mnmA(+)
trn0057 124,989 .. 125,051 63 3 SP_0120(+) SP_0121() (+)
trn0093 200,024 .. 200,092 69 1 SP_0223() rpsH(+)
trn0156 284,018 .. 284,090 73 1 SP_0311(+) SP_0312(+) (+)
trn0157 284,239 .. 284,316 78 1 SP_0311(+) SP_0312(+)
trn0218 392,084 .. 392,155 72 6 SP_0411() SP_0412() ()
trn0256 436,064 .. 436,160 97 1 SP_0460() SP_0461()
trn0273 466,477 .. 466,569 93 23 SP_0484(+) SP_0486(+) (+) 23S-methyl
(3.677E-13)
trn0290 497,393 .. 497,444 52 1 SP_0516(+) dnaK(+) (+)
trn0329 603,831 .. 603,887 57 1 SP_0640(+) SP_0641(+) (+)
trn0332 623,248 .. 623,309 62 56 SP_0648(+) SP_0650() SN11
trn0355 673,130 .. 673,199 70 1 SP_0707(+) SP_0709()
trn0358 684,651 .. 684,740 90 4 SP_0718(+) SP_0719(+) (+) TPP Riboswitch
(1.598E-18)
trn0423 800,595 .. 800,664 70 1 SP_0854(+) SP_0855(+)
trn0485 950,119 .. 950,196 78 1 SP_1004(+) SP_1006() (+)
trn0489 959,291 .. 959,352 62 1 dapA(+) trmE()
trn0498 985,718 .. 985,792 75 1 SP_1045(+) SP_1047(+)
trn0500 1,000,888 .. 1,000,974 87 2 SP_1065() SP_1067(+)
trn0510 1,016,417 .. 1,016,473 57 1 SP_1080(+) SP_1081(+)
trn0573 1,151,276 .. 1,151,348 73 1 ldh(+) SP_1221()
trn0591 1,189,881 .. 1,189,963 83 1 SP_1256() SP_1258()
trn0634 1,309,557 .. 1,309,634 78 1 SP_1384() SP_1385()
trn0663 1,390,993 .. 1,391,063 71 2 SP_1477() SP_1478() ()
trn0674 1,401,387 .. 1,401,457 71 3 SP_1490() SP_1491()
trn0696 1,423,633 .. 1,423,714 82 1 SP_1514() SP_1516() ()
trn0723 1,462,550 .. 1,462,631 82 1 SP_1552(+) SP_1553() (+)
trn0757 1,515,505 .. 1,515,588 84 1 SP_1612(+) recP-1() ()
trn0760 1,527,461 .. 1,527,537 77 1 SP_1625() rpsO() ()
trn0761 1,528,108 .. 1,528,175 68 2 SP_1625() rpsO () ()
trn0788 1,597,524 .. 1,597,579 56 1 SP_1692(+) SP_1694()
trn0830 1,731,046 .. 1,731,098 53 1 SP_1818(+) SP_1819()
trn0866 1,808,564 .. 1,808,655 92 7 SP_1900(+) tRNASer() ()
trn0883 1,831,635 .. 1,831,700 66 1 SP_1922() SP_1923()
trn0884 1,831,707 .. 1,831,795 89 1 SP_1922() SP_1923() ()
trn0909 1,870,117 .. 1,870,201 85 3 rpoB() tRNACys(+) ()
trn0935 1,903,551 .. 1,903,633 83 2 SP_1999() SP_2000() ()
trn0978 1,986,229 .. 1,986,311 83 1 SP_2075() SP_2077()
trn1009 2,014,191 .. 2,014,265 75 1 SP_2103(+) SP_2104()
trn1025 2,048,577 .. 2,048,644 68 1 SP_2136() SP_2138(+) SN46
trn1031 2,069,774 .. 2,069,864 91 2 SP_2153(+) SP_2156()
trn1052 2,132,378 .. 2,132,464 87 1 SP_2210(+) tsf()
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a high evolutionary pressure to maintain these sRNAs in
the pneumococcal lineage.
Expression and target prediction
of the intergenic sRNAs
The first step to demonstrate that these sRNAs are, indeed,
functionally required for gene regulation is to confirm their
independent expression. We concentrated on those RNAs
that were longer than 99 nt and chose several of the most
highly expressed as well as some apparently interesting
sRNA candidates for experimental validation by both RT-
PCR and Northern blot analysis. All 17 sRNAs selected
for validation (Table 1) were detected by RT-PCR, and 14
of them were also successfully detected by Northern blot-
ting (Figs. 3–6, see below). In every case, the Northern blot
showed a discrete band with a size similar to the predicted
sRNA, and in some cases, the blot also showed additional
bands.
sRNAs belonging to known families
The three housekeeping sRNAs identified—the RNase P
(srn098), the tmRNA (srn226), and the 6S RNA (srn395)—
are known to undergo processing to produce the mature
form in other bacteria (Fig. 3; Sakamoto et al. 1983; Lin-Chao
et al. 1999; Kim et al. 2005; Trotochaud and Wassarman
2005; Barrick et al. 2008). RNase P is the catalytic RNA
component of the ribonuclease P, a ubiquitous, essential
ribonucleoprotein complex found in all three domains of
life. It is one of the only two examples of RNA-based
enzymes whose role is to catalyze the 59-end maturation
of the pre-tRNA as well as the cleavage of other naturally
occurring substrates, such as the 4.5S RNA, tmRNA, operon
mRNAs, or some transient structures in riboswitches (for
review, see Kazantsev and Pace 2006; Hartmann et al. 2009;
Esakova and Krasilnikov 2010). The tmRNA is the putative
transfer messenger RNA responsible for ribosome rescue
and aberrant peptide tagging in the trans-translation pro-
cess (Gillet and Felden 2001). The 6S RNA binds to s70
RNA polymerase holoenzyme to globally regulate gene
expression in adaptation to stationary phase. The Northern
blot for these three sRNAs showed bands that correspond
to the predicted size of the mature transcripts as well as
bands corresponding to preprocessed forms and/or stable
degradation products (Fig. 3). Whether all of these forms
or only one of them is functional in pneumococcus remains
to be elucidated.
srn176, srn308, and srn029 appear to be cis-acting reg-
ulatory elements that are able to regulate the expression of
downstream genes upon binding to metabolites or proteins.
The mechanism of regulation typically involves a confor-
mational change in the secondary structure of the RNA
that serves to regulate the expression of a downstream gene
through a variety of mechanisms. Often, cis-regulatory
elements include an intrinsic terminator or an attenuator
structure in their sequence, which is usually formed upon
binding of the target molecule, thereby terminating tran-
scription. Expression regulation by premature transcription
termination results in the synthesis of the corresponding
small transcript. In agreement with this, Northern blot of
srn176 showed a specific band that was slightly longer than
the predicted size (Fig. 4A). Interestingly, srn176 is en-
coded by two relatively close regions of the genome, named
srn176_1 (also identified by Kumar et al. 2010) and
srn176_2, which shares 90% sequence identity (Fig. 4A).
Both srn176_1 and srn176_2 appear by Rfam prediction to
be TPP cis-acting regulatory elements that are able to bind
thiamine pyrophosphate (vitamin B1), an essential cofactor
for several important enzymes in carbohydrate metabolism,
and to regulate the expression of the downstream gene
(Winkler et al. 2002). Sequence inspection of the srn176
coding regions revealed a putative promoter at 10
(differing only in one base from the consensus sequence)
and 35 for srn176_1 and a consensus putative extended
promoter for srn176_2 (Fig. 4A). Additionally, in both
srn176_1 and srn176_2, the presence of a stretch of T’s at
the 39 end suggests the formation of a Rho-independent
transcriptional terminator structure, which would termi-
nate transcription, causing the accumulation of the srn176
transcript.
Similarly, srn308 was identified as an L10 leader region,
a family of autoregulatory structures found in the 59 UTRs
of the operon mRNAs encoding ribosomal proteins L10
and L12 (rplJ-rplL) (Zengel and Lindahl 1994). These
proteins form a complex that is able to bind specifically
to the leader sequence of the rplJ-rplL mRNA, disturbing
a specific secondary structure and inhibiting translation
of the encoded ribosomal proteins (Johnsen et al. 1982).
FIGURE 3. Northern blot analysis of three highly conserved house-
keeping sRNAs that were isolated from the S. pneumoniae TIGR4
strain: RNase P, tmRNA, and 6S RNA. (Arrows) The specific bands
detected by Northern blotting; (asterisks) the band of sRNA detected,
which agrees with the size predicted by sequencing.
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Multiple sequence alignments of several bacterial L10 leader
regions that are available in Rfam revealed a stretch of
z135 nt with four highly conserved sequence motifs that
are all present in srn308, including a Rho-independent tran-
scriptional terminator. Accordingly, Northern blot analysis
of srn308 revealed the accumulation of a small z130-nt
transcript in the conditions tested (Fig. 4B), which may be
the result of transcription termination at the putative Rho-
independent terminator.
srn029 appears to be an FMN riboswitch (also known as
a RFN), a highly conserved RNA element frequently found
in the 59 UTRs of prokaryotic mRNAs that encode flavin
mononucleotide (FMN) biosynthesis and transport pro-
teins (Vitreschak et al. 2002). In fact, srn029 is located 75 nt
upstream of a riboflavin biosynthesis protein gene. This
element is a metabolite-dependent riboswitch that binds
FMN in the absence of proteins and controls gene expres-
sion by causing premature transcription termination or
FIGURE 4. Detection, genomic context, and sequence of sRNAs isolated from the S. pneumoniae TIGR4 strain. (A) srn176, (B) srn308, (C) srn029,
(D) srn142, and (E) srn299. The arrows indicate the size of the sRNA detected by Northern blotting, which agrees with the size predicted by
sequencing. (C) RNA molecular weight marker. (Shadowed rectangles) The coordinates in the genome and the flanking genes for each sRNA. (Open
circles) A potential intrinsic terminator. The nucleotide sequence of each sRNA (shadowed) is also shown, where the putative promoters at 10, or
10 extended, and 35 boxes are labeled with an empty rectangle, and the consensus nucleotides are depicted in bold letters. Potential terminators
are shown in italic, bold letters, and putative ribosomal binding sites (RBS) and start codons of downstream genes (M) are in bold, underlined letters.
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precluding access to the ribosome-binding site (Mironov
et al. 2002). Northern blotting revealed several specific
bands with similar intensity (Fig. 4C). The shortest band
detected likely corresponds to the 155-nt sRNA identified
by pyrosequencing, whereas the other bands may correspond
to longer species, which may be derived from alternative
terminator structures or may be srn029 precursors. Whether
all of these forms or only one of them are functional remains
unknown.
As mentioned above, srn142 appears, from our analysis,
to be an antisense RNA whose 39 end overlaps with the 39
end of the adjacent gene (SP_0487) in a tail-to-tail manner
(Fig. 4D). However, srn142 corresponds to SN10 RNA,
which was previously identified as a shorter intergenic
sRNA that lacked the overlapping region (Kumar et al.
2010). Often, the criteria used for ORF predictions are not
sufficiently restricted, and several misannotations can be
found in certain genomes. Indeed, it is suspected that 30%
of genomes are overannotated (Frishman 2007), suggesting
that a substantial portion of the ORFs shorter than 300 nt
may not actually encode polypeptides. This might be the
case with SP_0487, which is only 219 nt in length and
theoretically encodes a 73-amino-acid peptide. SP_0487 has
an uncommon start (UUG) and stop (UAG) codon and
no putative Shine-Dalgarno sequence. Moreover, SP_0487
exhibits a fivefold overabundance of rare pneumococcal
codons (#0.5% occurrence, #12% of all isocodons) and
has not been identified as an ORF in pneumococcal genomes
other than S. pneumoniae TIGR4. Additionally, a sequence
search against the Rfam database confidently indicated that
srn142 is a member of the FMN family of cis-regulators.
Northern blots for srn142 showed a prominent band slightly
longer than the predicted size, and sequence inspection re-
vealed a putative promoter and a Rho-independent termi-
nator localized inside the putative SP_0487 gene (Fig. 4D).
Therefore, all data strongly suggest that SP_0487 is not a
polypeptide-encoding ORF and that srn142 is, indeed, an
intergenic sRNA, which acts as a cis-regulator modulating
the expression of the SP_0488 downstream gene through
premature transcription termination.
srn299 is encoded in the IGR between the bifunctional
pyrimidine regulatory protein PyrR uracil phosphoribosyl-
transferase (SP_1278) and the endonuclease III (SP_1279)–
encoding genes. According to our analysis, srn299 is 119 nt
long and has no significant homology within the Rfam
database. However, this sRNA overlaps with SN42, which
was previously identified as a member of the PyrR family
(Kumar et al. 2010), an RNA element found upstream of
genes involved in pyrimidine biosynthesis and transport.
srn299 is shorter than SN42 and lacks the 20-nt sequence at
the 59 end that contains the PyrR motif (Fig. 4E), which
explains the absence of Rfam homology. In B. subtilis,
binding of the PyrR protein to three attenuation sites at the
59 end of different pyr genes allows a terminator hairpin to
form, which represses the downstream pyr genes of the pyr
operon (Bonner et al. 2001). Our Northern blot showed
a prominent band corresponding to the predicted size of
srn299, although other larger and less intense bands were
also detected (Fig. 4E). Therefore, several srn299 RNA species
may coexist inside the cell at certain conditions, and all of
them may be functional.
The evidence suggests that srn176, srn308, srn142, srn029,
and srn299, although encoded in IGRs, are indeed cis-
regulatory RNAs that probably modulate the expression of
downstream genes by premature transcription termination.
Such a mechanism may lead to the accumulation of small
transcripts inside the cell under certain conditions, which
would then have the potential to function in trans on other
mRNAs. Very recently, a riboswitch element was discovered
in L. monocytogenes that, in addition to cis-regulating the
downstream gene, has the ability to act in trans to modulate
the expression of a distantly encoded mRNA (Loh et al.
2009; Xayarath and Freitag 2009). Taking into account the
intracellular accumulation of srn176, srn308, and srn142,
as detected by Northern blot analysis, it is tempting to
speculate about the possibility of these RNAs acting either
in cis or in trans to regulate the expression of different
mRNAs under certain conditions, as occurs in L. mono-
cytogenes. However, further studies will be necessary to
investigate this possibility.
sRNAs of unknown families
Six other intergenic sRNAs were analyzed by Northern blot:
srn135, srn206, srn266, srn400, srn491, and srn502. These
sRNAs did not show homology with the Rfam database,
and four of them were novel candidates (srn135, srn206,
srn266, and srn400). srn135, srn206, and srn502 showed a
single and specific band by Northern blotting that corre-
sponded to their predicted sizes (Figs. 5A,C, 6B), while
srn266 and srn400 exhibited several bands (Fig. 5B,D). With
regard to srn491, its coding strand could not be identified
because a poly(C) tail was not detected in any of the cDNA
reads assembled. Therefore, to assess its orientation, probes
complementary to both strands were used in the Northern
blot analysis. A band corresponding to the predicted size
was detected only with the forward oligonucleotide, indi-
cating that srn491 is encoded on the negative strand, as are
the flanking genes (Fig. 6A).
To understand the possible roles of these six sRNAs, they
were subjected to target prediction by TargetRNA analysis.
This program is designed to identify putative mRNA
targets by searching for interrupted base-pair interactions
within intergenic regions (Tjaden et al. 2006). In addition,
their secondary structure was also analyzed using RNAfold
prediction (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi).
TargetRNA analysis of srn135, srn266, srn400, and srn502
resulted in at least one confident putative mRNA target
for each of them (P-values between 1.15E-3 and 1.39E-4),
and some of these targets appear to be interesting. For
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instance, srn135 appears to base-pair with the initiating
translation region of the permease protein of the drug efflux
ABC transporter (SP_1342), which has been theorized to
have a role in antibiotic resistance, while the best targets for
srn266 are a set of transposase-encoding genes (IS1167).
However, the four sRNAs were predicted to be highly
structured (DG between 23.10 and 79.47 kcal/mol), and
in all cases, the region involved in base-pairing with their
mRNA targets was included in a highly stable stem structure
(Fig. 5A–D), thus raising doubt on the target predictions.
Therefore, additional experiments will be required to assess
the function of these sRNAs.
In the case of srn491, the secondary structure prediction
and TargetRNA analysis predicted a base-pairing between
the sequence in the bubble of srn491, which was therefore
available for interaction, and the translation start site of the
SP_1680 mRNA in the TIGR4 genome (Fig. 6A). SP_1680
encodes a hypothetical protein that, upon BLAST analysis,
appeared to belong to the DUF386 superfamily, a group
of conserved, hypothetical proteins of unknown function.
FIGURE 5. Detection, predicted secondary structure, and target prediction of sRNAs isolated from the S. pneumoniae TIGR4 strain. (A)
srn135, (B) srn266, (C) srn502, and (D) srn400. The arrows indicate the size of the sRNA detected by Northern blotting, which agrees with the
size predicted by sequencing. (C) RNA molecular weight marker. The putative mRNA targets for srn135, srn266, srn502, and srn400 (P-values
of 9.08 3 104, 1.77 3 104, 1.39 3 104, and 1.15 3 103, respectively) predicted by TargetRNA software are shown. The secondary
structures were predicted using RNAfold server (DG values of 14.6, 28.2, 79.5, and 23.1 kcal/mol for srn135, srn266, srn502, and srn400,
respectively). The sRNA region predicted to associate with the target mRNAs is highlighted in gray. The start codons and SD are in bold,
underlined letters.
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Therefore, association between srn491 and its putative mRNA
target through an antisense mechanism would negatively af-
fect SP_1680 translation.
Interestingly, TargetRNA analysis of srn206 rendered sev-
eral putative mRNA targets with very low P-values, although
the strongest candidate (P-value=4.88E-5) corresponded to
comD mRNA. ComD protein is the histidine kinase that
senses the competence-stimulating peptide (CSP), which is
responsible for the induction of competence for genetic
transformation in S. pneumoniae. Pneumococcus is a natu-
rally competent bacterium that is able to incorporate ex-
ogenous DNA into the genome through an uptake and
recombination process controlled by the competence ma-
chinery. The extracellular concentration of CSP, an exported
peptide pheromone derived from the precursor protein
ComC, is sensed by the ComD receptor. Binding of CSP
to ComD results in phosphorylation of ComD, which trans-
fers the phosphate group to the cognate response regulator
ComE, which then activates transcription of early compe-
tence genes (Claverys et al. 2009; Johnsborg and Havarstein
2009). ComC, ComD, and ComE are cotranscribed in a long
mRNA transcript, and its transcription is activated by
P-ComE. srn206 is predicted to associate with this mRNA
transcript in the translation start region of ComD, seques-
tering its start codon and ribosome-binding site (Fig. 6B).
Moreover, secondary structure prediction of srn206 by
RNAfold revealed that, although highly structured, the
region predicted to base-pair with ComD mRNA is primar-
ily located in a bubble and is therefore free to interact with
its target (Fig. 6B). Inhibition of translation of ComD by
srn206 would affect the activation of the competence cas-
cade, preventing transformation of pneumococcal cells.
srn206 and competence development
To test whether srn206 was, in fact, involved in modulating
competence, a mutant strain lacking the srn206 gene was
constructed through insertion/deletion of a Cm resistance
FIGURE 6. Detection, genomic context, predicted secondary structure, and target prediction of sRNAs isolated from the S. pneumoniae TIGR4 strain.
(A) srn491 and (B) srn206. srn206 was detected with a probe labeled internally with biotin, whereas srn491 was hybridized to either forward or reverse
biotinylated oligonucleotides, as indicated. The arrows indicate the size of the sRNA detected by Northern blotting, which agrees with the size predicted
by sequencing. (C) RNA molecular weight marker. The shadowed rectangles show the coordinates in the genome and the flanking genes for each sRNA.
The figure also shows candidate mRNA targets for srn491 and srn206 (P-values of 3.63 3 103 and 4.88 3 105, respectively) predicted by TargetRNA
software. The secondary structures were predicted using RNAfold server (DG values of 29.8 and 26.9 kcal/mol for srn491 and srn206, respectively).
The sRNA region predicted to associate with the target mRNA is highlighted in gray. The start codons and SD are in bold, underlined letters.
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gene. The transformation efficiency of wild-type (wt) and
mutant strains was assayed using streptomycin-resistant
(Smr) chromosomal DNA. Six independent experiments
were performed with both strains. The results showed that,
as expected, the wt strain became competent only in re-
sponse to exogenous CSP, and no transformants were ob-
tained without the inducer (Table 3). In contrast, in two of
the six experiments, the TIGR4srn206- mutant was able to
accept exogenous DNA in the absence of CSP to levels that
were sevenfold higher than those reached in the presence
of the inducer (Table 3). However, in the following four
experiments, the srn206- mutant behaved like the wt, and
no transformants were obtained without CSP. The spon-
taneous competence phenotype displayed by the mutant
strain in some experiments would be consistent with the
postulated role of srn206 in ComD translational repression.
The uptake of DNA in the absence of inducer never occurs
in the wild type, and, therefore, the capacity of the mutant
to become spontaneously competent in some experiments
is suggestive of a role of srn206 in competence modulation.
Competence induction is highly stressful for the cell and
needs to be tightly controlled. Therefore, it is likely that the
mutant strain has suffered a secondary mutation that com-
pensates the detrimental effect of having the competence
system constantly on.
To overcome this problem, we cloned a chromosomal
region containing the srn206 gene in the pLS1cop7 plasmid
(named as pLScop herein), a high-copy-number mutant
derivative of the promiscuous streptococcal plasmid pLS1
(del Solar et al. 1987). The constructed plasmid, pLScop-
206, which allows the expression of srn206 from its natural
promoter, was introduced in wild-type TIGR4 cells through
transformation. Quantification by RT-qPCR revealed that
the expression of srn206 in TIGR4[pLScop-206] cells was
38-fold higher than that obtained in the control cells
(TIGR4[pLScop]). Such overexpression caused approxi-
mately a threefold reduction in the transformation effi-
ciency of pLScop-206-containing cells in a competence assay
(Table 3), and this reduction was significant, as shown by
the Student’s t-test (P-value=0.016). These results are in
agreement with our predictions and suggest that srn206 is
involved in competence modulation. Whether the action of
snr206 is mediated through ComD translational repression
or not needs to be investigated, and further experiments are
required to address the precise function of srn206. However,
although preliminary, our data point to this sRNA as one of
the factors involved in the maintenance of the competence
on–off switch in pneumococcus.
CONCLUSIONS
In this study, we describe the identification of a reper-
toire of small regulatory RNAs in the human pathogen
S. pneumoniae TIGR4 that can be generally classified as
59- or 39-overlapping RNAs and sRNAs from IGRs. The 88
sRNAs identified include several previously described sRNAs
and 68 novel candidates. Combining all previous and present
data, a total of 118 sRNA candidates have been identified
to date in the S. pneumoniae TIGR4 strain, and 50 others
have been computationally predicted to be encoded in IGRs.
Therefore, it appears that, although smaller, the pneumo-
coccal genome encodes a similar number of sRNAs as
B. subtilis (Irnov et al. 2010), the classical model microorgan-
ism for Gram-positive bacteria. These numbers are also close
to the 200–300 sRNAs that have been estimated to be present
in the average bacterial genome (Hershberg et al. 2003).
In this study, we have combined high-throughput pyro-
sequencing and low-throughput analyses for complete de-
tection of the sRNA pool of pneumococcus. A set of mRNA
targets was predicted for some of the sRNAs, and interesting
TABLE 3. Competence for transformation in wild-type (WT), srn206 mutant (206), and wild type with plasmid pLScop (WT[cop7])







Strain +CSP CSP +CSP CSP +CSP
WT 7 6 5 None 1.66 6 0.86 <0.001 100
206 11 6 2 84 6 39 0.33 6 0.07 2.30 6 0.73 20
WT [cop7] 5 6 2 None 1.29 6 0.63 <0.001 100
WT [cop7-206] 2 6 1 None 0.39 6 0.23 <0.001 30
aThe average number of transformants was determined by at least four independent experiments, except in the 206 mutant in which only two
experiments were considered. The range of standard deviation is also shown. ‘‘None’’ indicates that no transformants were observed when 200 mL
of the transformation mixture was plated on selective plates.
bThe transformation efficiency is the percentage of transformants regarding the total number of cells obtained on each culture. Note that the
average total number of cells in WT, 206mutant, WT[cop7], and WT[cop7-206] strains were 3.493107, 3.263108, 4.283107, and 7.733107 in
the presence of CSP, and 8.423107, 3.453108, 4.553107, and 6.733107 in the absence of CSP, respectively. The average of at least four (WT with
or without plasmids) or two (206) independent experiments and standard deviations are presented. The means obtained with WT[cop7] and
WT[cop7-206] were compared by the student’s t-test and the P-value was 0.016, showing that the difference observed was significant (using
a confident level of 95%).
cYield of transformation compared with the corresponding CSP-induced control cells (WT or WT[cop7]).
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findings were obtained. For instance, the sRNA srn206 is
suggested to modulate the expression of the histidine kinase
sensor that allows entrance into a competent state in pneu-
mococci. Competence is a pivotal mechanism in S. pneumo-
niae and is involved in virulence and antibiotic resistance
(Lau et al. 2001; Oggioni et al. 2004; Prudhomme et al. 2006;
Kowalko and Sebert 2008), and its modulation would
certainly affect many important aspects in pneumococcal
pathogenesis. The core portion of the pneumococcal com-
petence regulatory cascade is well understood. However,
the signals that trigger competence are still unknown, and
deciphering this question may help us better understand the
role of competence. Our results suggest that srn206 may be
one of the players involved in the maintenance of the
competence on–off switch in pneumococcus, and its re-
lationship with the ComD protein needs to be explored.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions
All studies were performed in the TIGR4 strain of S. pneumoniae
(serotype 4). Cloning experiments using the pLS1cop7 plasmid
kindly provided by Dr. G. del Solar (del Solar et al. 1987), named
as pLScop herein, were carried out in the R6 strain of S. pneumo-
niae. For cloning in the pGEM-T Easy vector (from Promega), the
E. coli DH5a [F, ø80dlacZDM15, D(lacZYA-argF)U169, deoR,
recA1, endA1, hsdR17(rK, mK+), phoA, supE44, l, thi-1, gyrA96,
relA1] was used. For 454 pyrosequencing, RT-PCR, and Northern
blot analyses, pneumococcal cells were grown as a static culture in
Todd-Hewitt medium supplemented with 0.5% yeast extract (THY)
to an optical density at 600 nm (OD600) of 0.4–0.5. Then the culture
was diluted 12-fold in the same medium (preheated), and growth
continued to OD600=0.2. Cells were cooled on ice, centrifuged, and
used for RNA extraction.
RNA isolation
For total RNA extraction, pneumococcal cultures were centrifuged
at 6000g for 10 min, and the cellular pellet was resuspended in
0.15 culture volumes of Lysis Solution (50 mM Tris at pH 8.0,
10 mM EDTA, and 0.1% sodium deoxycholate) and lysed by
incubation for 5 min at 37°C. Total RNA was isolated using
TRIzol Reagent (Invitrogen), following the instructions from the
manufacturer. The integrity of the rRNAs was checked by gel
electrophoresis through a 0.8% agarose gel, and the RNA concen-
tration was determined using a NanoDrop ND-1000 Spectropho-
tometer. Total RNA was treated with DNase I (Roche) to remove
residual genomic DNA, precipitated, and stored at 80°C in
nuclease-free water.
For pyrosequencing, the total RNA was further processed to
enrich the sample for small-sized RNAs and to deplete the 5S
rRNA as follows: Total RNA isolated from 24 mL of culture was
subjected to two consecutives steps of size fractionation and
elution on denaturing 8% polyacrylamide (PAA)/7 M urea gels in
13 TBE buffer. In the first step, RNAs between 50 and 500 nt in
length were selected, eluted from the gel, and ethanol-precipitated
as described (Conrad et al. 1998). The small RNA pool recovered
(50–500 nt) was again gel-fractionated on a PAA/7 M urea gel,
and the RNA fraction between 100 and 400 nt in length was
extracted following the same procedure. To deplete the 5S rRNA
from the small RNA pool (the predominant RNA species within
the size-range selected), a complementary, biotinylated oligonu-
cleotide [59-(T15)-GGCTTAACTTCTGTGTTCGGCATGGGTA-39]
and streptavidin magnetic beads (Roche Applied Science) were used
following a procedure previously described (Pang et al. 2004).
Briefly, 125 mL of streptavidin magnetic beads was washed three
times with 0.53 SSC (75 mM NaCl and 7.5 mM Na citrate at
pH 7), mixed with 720 pmol of 5S rRNA biotin-labeled oligonu-
cleotide, and incubated at room temperature for 30 min. RNA
was resuspended in 0.53 SSC, incubated for 5 min at 70°C for
denaturing, and chilled on ice. Then the RNA sample was trans-
ferred to previously prepared biotin-labeled oligonucleotide mag-
netic beads and incubated for 30 min at 68°C to allow hybridization
to occur. A magnet was applied to the bottom of the tube, and
the supernatant was carefully transferred into a clean, RNase-free
microcentrifuge tube, precipitated and resuspended in 60 mL
of water. This procedure was repeated twice, and the remaining
5S rRNA in the sample was measured by RT-qPCR using the specific
primers 5S-F: 59-GTGACGATAGCCTAGGAGATACACCTG-39
and 5S-R: 59-CCCTATCTCACAGGGGGCAAC-39.
cDNA synthesis and pyrosequencing analysis
To synthesize the cDNA for pyrosequencing, the small RNA pool
remaining after 5S rRNA depletion was first C-tailed using 3.5 U
of E. coli poly(A) polymerase (Ambion) and 1 mM CTP for 60
min at 37°C in a 105-mL volume. Unincorporated nucleotides
were removed from the mixture using NucAway Spin columns
(Ambion). For first-strand cDNA synthesis, the SuperScript
Plasmid System with Gateway Technology from Invitrogen was
used. For this purpose, 9.6 mg of C-tailed RNA was split into three
tubes, and each 3.2-mg aliquot of RNA was hybridized with 1 mg
of a poly(G) oligonucleotide (59-TCGCGAGCGGCCGCG15-39)
for 10 min at 70°C in 9.5 mL. Then 200 U/mg SuperScript II re-
verse transcriptase (Invitrogen), 0.2 mM dNTPs, and 0.25 mM
DTT were added to each tube and incubated for 1 h at 45°C for
reverse transcription. For second-strand synthesis, 25 mM Tris-HCl
(pH 7.5); 100 mM KCl; 5 mM MgCl2; 10 mM (NH4)2SO4; 0.15 mM
b-NAD+; 250 mM each of dATP, dCTP, dGTP, and dTTP; 1.2 mM
DTT; 65 U/mL DNA ligase; 250 U/mL DNA polymerase I; and 13
U/mL RNase H were added to the mixtures to a final volume of
150 mL. After gentle mixing, the reaction was incubated for 2 h at
16°C. Then 2 mL (10 U) of T4 DNA polymerase was added, and
incubation continued for 5 min at 16°C. After that, cDNA was
purified using a QIAquick PCR Purification Kit from QIAGEN.
Finally, 3.7 mg of cDNA was obtained and subjected to pyrose-
quencing using 454 sequencing on the Genome Sequencer FLX
System from the Lifesequencing S.L. company. The resulting cDNA
sequences were mapped onto the S. pneumoniae genome (Tettelin
et al. 2001) using Reference Mapper software from Roche.
Real-time PCR
PCR primers were designed (listed in Supplemental Table S5) using
Oligo Perfect Designer software (Invitrogen). cDNA synthesis was
performed with the Transcriptor First Strand cDNA Synthesis
Kit from Roche Applied Science following the instructions from
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manufacturers. Briefly, 1 or 2 mg of total RNA and 60 mM of
random hexamers were mixed in a 13-mL reaction volume, in-
cubated for 10 min at 65°C, and immediately annealed for 10 min at
4°C. Reverse transcription was carried out in a 20-mL reaction
volume with 10 U of Transcriptor Reverse Transcriptase (+RT), 10
mM each dNTP, and 20 U of Protector RNase Inhibitor in the
reaction buffer. The mixture was incubated for 10 min at 25°C,
followed by 30 min of incubation at 55°C. Finally, the reverse
transcriptase was inactivated by incubation for 5 min at 85°C.
A mock cDNA synthesis reaction was performed, with the reverse
transcriptase replaced by water (RT). For each sRNA, at least
two different RT reactions were set up.
For validating the expression of sRNAs, PCR reactions were
performed with the LightCycler Carousel-Based System for Real-
Time PCR (Roche Applied Science) using primers specific for each
sRNA. Reactions were carried out using 1 mL of cDNA (+RT and
RT), 0.25 mM each primer, and 11 mL of SYBRPremix Ex Taq
(Takara) in a 22-mL reaction volume. Ten-microliter duplicates were
loaded on the LightCycler capillaries. A three-step PCR protocol
(5 min at 95°C, then 45 cycles of 10 sec at 95°C, 20 sec at 60°C, and
15 sec at 72°C) was used. The temperature transition rates were
programmed at 20°C/sec. After PCR completion, a melting curve
was recorded by cooling to 65°C at 20°C/sec, holding for 15 sec at
65°C, and then heating slowly at 0.1°C/sec until 95°C was reached.
Samples were then cooled for 30 sec to 40°C.
For quantification of the srn206 expression, reactions were
performed as described above using the LightCycler 480 System
for Real-Time PCR (Roche Applied Science). 16S rRNA was used
as the internal reference gene. The gene-specific primer pairs used
were srn206q and 16Sq for the srn206 and the 16S rRNA, respec-
tively (Supplemental Table S5). A calibration curve using the PCR
product obtained with srn206q primers was used for quantification.
To estimate variation in the technique, two technical and two
biological replicates were carried out.
Northern blot
Total RNA samples (10 or 20 mg) were heated for 10 min at 80°C
in 13 formamide containing Gel Loading Buffer II (Ambion) and
fractionated in a 6% PAA/7 M urea gel. RNAs were transferred to
Hybond-N+ membrane (Amersham) by electroblotting, using the
Trans-blot cell from Bio-Rad in 13 TAE buffer according to the
manufacturer’s instructions. The blots were UV-cross-linked in
a CL-1000 UV Crosslinker (UVP, Inc.) by two cycles of irradiation
at 254 nm and 1200 J and then prehybridized for at least 10 min
with PerfectHyb Plus buffer (Sigma-Aldrich). Hybridization was
performed overnight with either 20 ng/mL internally labeled
biotinylated DNA (0.1 mL/cm of membrane) or 50 pmol of 59-
biotin-labeled oligonucleotides as probes (listed in Supplemental
Table S5) at the appropriate hybridization temperature for each
probe in the same hybridization buffer. Detection was performed
by autoradiography using a Phototope-Star Detection kit from
New England Biolabs. Internally labeled biotinylated DNA probes
were synthesized using the NEBlot Phototope Kit from New
England Biolabs through a random primer reaction with biotiny-
lated dATP. The template for the labeling reaction was generated
by standard PCR using 10 pmol of the specific primers for each
sRNA (listed in Supplemental Table S5), 200 mM dNTPs, and
FastStart Taq DNA polymerase from Roche. All PCRs were purified
using the QIAquick PCR Purification Kit from QIAGEN. Labeling
was then performed with 100 ng of each specific PCR for each
sRNA following the instructions from the manufacturer and further
purified with NucAway Spin columns from Ambion, Inc. to remove
unincorporated nucleotides.
Transformation of pneumococcal cells
Cultures of S. pneumoniae TIGR4 grown in a casein hydrolase–
based medium (AGCH) with 0.2% sucrose (Suc) and 0.001%
CaCl2 containing 1.5 3 10
7 CFU/mL were treated with 75 ng/mL
CSP-2 for 20 min at 30°C. After that, DNA was added, and the
culture was incubated for 40 min at 30°C, then transferred to a
37°C water bath and incubated for 90 min to allow expression
of the antibiotic resistance marker. When the antibiotic was Cm,
after 70 min at 37°C, 0.5 mg/mL Cm was added to the culture to
induce the expression of the antibiotic-resistance gene, and the cells
were incubated for 20 min more. After that, transformants were
plated on media plates (AGCH medium with 1% agar plus 0.3%
Suc and 0.2% yeast extract) containing the corresponding antibi-
otic. Transformants were grown at 37°C in a 5% CO2 atmosphere.
Construction of the srn206 mutant
strain of S. pneumoniae
The srn206-deficient mutant was created through allelic replace-
ment mutagenesis (Song et al. 2005). A fragment upstream of the
srn206 gene was amplified with primers S206-F (59-TCCTCCGA
AAGCTGTCGAA-39) and S206-CAT-R (59-TTCTTTGTTCCACG
CTTACTACGAGATTTCGCTTGAGTCTGC-39), and a fragment
downstream from srn206 was amplified using primers S206-CAT-F
(59-TACAGCTCCAGATCCATATCAGTCTGCTTGGCTAGGAA
G-39) and S206-R (59-CTTGCTGAAGGTGCCTTTC-39) from the
TIGR4 genome. The chloramphenicol-resistance cassette (Cmr) was
amplified from the pJS3 plasmid (Ballester et al. 1986) using CAT-F
(59-GTAGTAAGCGTGGAACAAAGAA-39) and CAT-R (59-GATA
TGGATCTGGAGCTGTA-39). The three PCR reactions were mixed
together and amplified using the S206-F and S206-R oligonucleo-
tides. Finally, a 3266-bp PCR fragment in which a 69-nt internal
region of the srn206 encoding gene was replaced by a Cmr marker
was obtained. This fragment was used to transform TIGR4
competent cells of S. pneumoniae. One Cmr transformant was
selected, and the insertion/deletion mutation was confirmed by
DNA sequencing.
Competence assay
Cultures of pneumococcal cells were started by inoculating AGCH
plus 0.3% Suc and 0.2% yeast extract (YE) with 1/1000 volume of
frozen stock cells. Growth was carried out at 37°C in a static water
bath. At an OD650 of 0.175, the cells were diluted in AGCH plus
0.3% Suc and 0.001% CaCl2 to an OD650 of 0.017 and allowed
to continue to grow. When the cultures reached an OD650 of
0.05, they were split in half. One-half was induced by addition of
75 ng/mL CSP2. After 14 min at 37°C, 100 ng/mL streptomycin-
resistance (Smr) chromosomal DNA from the RF46SKNE strain
(Lopez et al. 1984) was added to both the induced and uninduced
cultures, and then the cultures were incubated for 1 h at 37°C.
Then 0.1 mL of serial dilutions was plated on AGCH medium
with 1% agar plus 0.3% Suc and 0.2% YE either with or without
100 mg/mL streptomycin. Transformants were counted after 20 h
at 37°C in a 5% CO2 atmosphere.
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Cloning of srn206-encoding gene
A 718-bp genomic region containing the srn206 gene was amplified
from TIGR4 chromosomal DNA by standard PCR using Expand
High Fidelity (Roche) and primers RNA206F2 (59-GCGAAGCTT
GAAGTGACTGAACGTGTTAAA-39) and RNA206-R4 (59-CGCG
AATTCATCATCCGCTTGAGCTGG-39). The resulting PCR prod-
uct was cloned into a pGEM-T Easy vector using the pGEM-T Easy
vector system I from Promega and transformed into E. coli DH5a-
competent cells. The resulting plasmid, pG206, was digested with
EcoRI, and the 726-bp fragment containing the srn206 gene was
then cloned into the pLScop previously cut with EcoRI. The
resulting plasmid was designated pLScop-206 and was intro-
duced into wild-type pneumococcal cells by transformation.
Transformants were selected using 1 mg/mL Tc, and their sequence
was confirmed.
Bioinformatics
Genome sequences with ORF annotation and coordinates were
downloaded from the NBI FTP repository site (http://www.ncbi.
nlm.nih.gov/genomes/lproks.cgi). cDNA contigs were mapped on
all genomes using BLAST (Altschul et al. 1990) called by in-house
Perl scripts. Equivalent loci between pneumococcal strains were
assigned as the best mutual BLAST hit in their genomes. Free
energies of the secondary structures were calculated with RNAfold
from the Vienna suite (Hofacker et al. 1994)
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